For more than six decades, the National Institute of Allergy and Infectious Diseases, NIAID, has been at the forefront of important research in infectious and immune mediated diseases, microbiology, immunology and related disciplines. It conducts and supports basic and applied research to better understand, diagnose, prevent and treat infectious diseases such as HIV/AIDS, tuberculosis and malaria, as well as immune mediated disorders such as Lupus and Type I Diabetes. This work has led to new vaccines, therapeutics, diagnostics and other technologies that have improved health and saved millions of lives in the United States and around the world.
What are the strategic priorities of NIAID?
How is NIAID accelerating the findings from basic research into healthcare practice?
What has been learned from emerging and reemerging infectious diseases?
Michael J. Keegan, host, The Business of Government Hour, explores these questions and so much more with his very special guest Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases.